Dry blood spots would be taken for determination of Alpha Glucosidase activity using LC-MS-MS

Eligibility

Ages Eligible for Study:

up to 7 Days

Genders Eligible for Study:

Both

Accepts Healthy Volunteers:

Yes

Sampling Method:

Non-Probability Sample

Study Population

10000 full-term newborns born in Northern Israel

Criteria

Inclusion Criteria:

New born babies born during the study period

Exclusion Criteria:

Premature babies

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01409486

The study aims:
To establish the control mean values of alpha glucosidase activity in Dry blood spots of Newborn babies from Israel.
To include the alpha glucosidase assay in the newborn screening program in Israel